FDA Evaluating Regulations for Homeopathic Drugs

Drug Industry Daily
A A
Homeopathic drugs could face greater regulatory scrutiny by the FDA, as the agency weighs whether its existing regulations and enforcement policies are sufficient to deal with the dramatic uptick in natural products on the U.S. market.

To View This Article:

Login

Subscribe To Drug Industry Daily